Assuming the DOD eventually gets FDA approval to use immuron's new drug for ETEC (e coli ) Then as ETEC is the leading cause of travelers diarrhea and a major cause of diarrhea in poor countries , especially in children. Then immuron doesn't need to do a phase 3 trial for travelan as they can just use this new one all paid for by DOD Then they just get on with the $100 million a year revenue and bobs your uncle , right ??
IMC Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held
